EP3220935A4 - Isoform-specific calpain inhibitors, methods of identification, and uses thereof - Google Patents
Isoform-specific calpain inhibitors, methods of identification, and uses thereof Download PDFInfo
- Publication number
- EP3220935A4 EP3220935A4 EP15859500.9A EP15859500A EP3220935A4 EP 3220935 A4 EP3220935 A4 EP 3220935A4 EP 15859500 A EP15859500 A EP 15859500A EP 3220935 A4 EP3220935 A4 EP 3220935A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- isoform
- identification
- methods
- calpain inhibitors
- specific calpain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462078221P | 2014-11-11 | 2014-11-11 | |
PCT/US2015/060157 WO2016077461A2 (en) | 2014-11-11 | 2015-11-11 | Isoform-specific calpain inhibitors, methods of identification, and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3220935A2 EP3220935A2 (en) | 2017-09-27 |
EP3220935A4 true EP3220935A4 (en) | 2018-12-26 |
Family
ID=55955254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15859500.9A Withdrawn EP3220935A4 (en) | 2014-11-11 | 2015-11-11 | Isoform-specific calpain inhibitors, methods of identification, and uses thereof |
Country Status (7)
Country | Link |
---|---|
US (1) | US20190030114A1 (en) |
EP (1) | EP3220935A4 (en) |
JP (1) | JP2017538681A (en) |
CN (1) | CN107018651A (en) |
AU (1) | AU2015346371A1 (en) |
CA (1) | CA2963684A1 (en) |
WO (1) | WO2016077461A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113228201B (en) * | 2018-08-13 | 2023-03-07 | 健康科学西部大学 | Calpain-2selective inhibitor compounds for the treatment of glaucoma |
JP7138934B2 (en) * | 2018-10-11 | 2022-09-20 | 学校法人常翔学園 | Pharmaceutical composition containing an apelin receptor agonist having retinal neuroprotective action |
WO2021163631A1 (en) * | 2020-02-12 | 2021-08-19 | Western University Of Health Sciences | Calpain-2 inhibitor compounds and methods of treatment |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6235929B1 (en) * | 1991-12-27 | 2001-05-22 | Georgia Tech Research Corporation | Tripeptide α-ketoamides |
US20040248795A1 (en) * | 2003-01-07 | 2004-12-09 | Rodney Guttmann | Membrane-permeable peptide capable of calpain inhibition |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06504061A (en) * | 1990-12-28 | 1994-05-12 | コーテックス ファーマシューティカルズ インコーポレイテッド | Use of calpain inhibitors in the treatment and prevention of neurodegeneration |
EP0564561A4 (en) * | 1990-12-28 | 1994-08-10 | Georgia Tech Res Inst | Peptides ketoamides, ketoacids, and ketoesters |
AU2001265137B2 (en) * | 2000-05-30 | 2007-06-14 | Indiana University Research And Technology Corporation | Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
CN100463901C (en) * | 2003-12-12 | 2009-02-25 | 千寿制药株式会社 | Alpha-ketoamide derivative, and production method and use thereof |
ES2331841T3 (en) * | 2003-12-12 | 2010-01-18 | Senju Pharmaceutical Co., Ltd. | DERIVATIVES OF ALFA-CETOAMIDE AND METHOD OF PRODUCTION AND USE OF THE SAME. |
WO2009099416A1 (en) * | 2008-02-06 | 2009-08-13 | Georgia Tech Research Corporation | Heterocyclic peptide ketoamides |
EP2689247B1 (en) * | 2011-03-25 | 2016-10-05 | Vib Vzw | Methods for screening inhibitors of tumour associated protein aggregation. |
-
2015
- 2015-11-11 CN CN201580061438.3A patent/CN107018651A/en active Pending
- 2015-11-11 US US15/525,849 patent/US20190030114A1/en not_active Abandoned
- 2015-11-11 EP EP15859500.9A patent/EP3220935A4/en not_active Withdrawn
- 2015-11-11 AU AU2015346371A patent/AU2015346371A1/en not_active Abandoned
- 2015-11-11 CA CA2963684A patent/CA2963684A1/en not_active Abandoned
- 2015-11-11 JP JP2017525371A patent/JP2017538681A/en not_active Ceased
- 2015-11-11 WO PCT/US2015/060157 patent/WO2016077461A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6235929B1 (en) * | 1991-12-27 | 2001-05-22 | Georgia Tech Research Corporation | Tripeptide α-ketoamides |
US20040248795A1 (en) * | 2003-01-07 | 2004-12-09 | Rodney Guttmann | Membrane-permeable peptide capable of calpain inhibition |
Non-Patent Citations (5)
Title |
---|
BARTUS R T ET AL: "POSTISCHEMIC ADMINISTRATION OF AK275, A CALPAIN INHIBITOR, PROVIDESSUBSTANTIAL PROTECTION AGAINST FOCAL ISCHEMIC BRAIN DAMAGE", JOURNAL OF CEREBRAL BLOOD FLOW & METABOLISM, NATURE PUBLISHING GROUP, US, vol. 14, 1 July 1994 (1994-07-01), pages 537 - 544, XP001019612, ISSN: 0271-678X * |
DÓKUS LEVENTE E ET AL: "Probing of primed and unprimed sites of calpains: Design, synthesis and evaluation of epoxysuccinyl-peptide derivatives as selective inhibitors", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 82, 24 May 2014 (2014-05-24), pages 274 - 280, XP028872860, ISSN: 0223-5234, DOI: 10.1016/J.EJMECH.2014.05.058 * |
HONGYUAN CHEN ET AL: "New Tripeptide-Based Macrocyclic Calpain Inhibitors Formed by N -Alkylation of Histidine", CHEMISTRY & BIODIVERSITY, vol. 9, no. 11, 1 November 2012 (2012-11-01), CH, pages 2473 - 2484, XP055415468, ISSN: 1612-1872, DOI: 10.1002/cbdv.201200320 * |
LI Z ET AL: "Novel Peptidyl alpha.-amide inhibitors of calpains and other cysteine proteases", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 39, 1 January 1996 (1996-01-01), pages 4089 - 4098, XP002180459, ISSN: 0022-2623, DOI: 10.1021/JM950541C * |
ZHAOZHAO LI ET AL: "PEPTIDE ALPHA-KETO ESTER, ALPHA-KETO AMIDE, AND ALPHA-KETO ACID INHIBITORS OF CALPAINS AND OTHER CYSTEINE PROTEASES", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 36, no. 22, 29 October 1993 (1993-10-29), pages 3472 - 3480, XP000565670, ISSN: 0022-2623, DOI: 10.1021/JM00074A031 * |
Also Published As
Publication number | Publication date |
---|---|
WO2016077461A2 (en) | 2016-05-19 |
US20190030114A1 (en) | 2019-01-31 |
CN107018651A (en) | 2017-08-04 |
EP3220935A2 (en) | 2017-09-27 |
JP2017538681A (en) | 2017-12-28 |
AU2015346371A1 (en) | 2017-04-27 |
CA2963684A1 (en) | 2016-05-19 |
WO2016077461A3 (en) | 2016-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2015342774B2 (en) | EZH2 inhibitors and uses thereof | |
EP3160477A4 (en) | Prmt5 inhibitors and uses thereof | |
EP3160466A4 (en) | Prmt5 inhibitors and uses thereof | |
EP3177288A4 (en) | Prmt5 inhibitors and uses thereof | |
EP3134091A4 (en) | Irak inhibitors and uses thereof | |
EP3193608A4 (en) | Carm1 inhibitors and uses thereof | |
EP3110820A4 (en) | Tyk2 inhibitors and uses thereof | |
EP3224815A4 (en) | Geolocation bracelet, systems, and methods | |
EP3188787A4 (en) | Methods and devices for transcarotid access | |
EP3185868A4 (en) | Novel ulk1 inhibitors and methods using same | |
EP3157466A4 (en) | Prostheticcapsular devices, systems, and methods | |
EP3385924A4 (en) | Identification method and identification medium | |
GB201421083D0 (en) | Enzyme inhibitors | |
EP3204006A4 (en) | Induction of gata2 by hdac1 and hdac2 inhibitors | |
EP3193611A4 (en) | Mk2 inhibitors and uses thereof | |
EP3116503A4 (en) | Hptp-beta inhibitors | |
GB201421088D0 (en) | New enzyme inhibitors | |
EP3445365A4 (en) | Ezh2 inhibitors and uses thereof | |
EP3341387A4 (en) | Sialyltransferase inhibitors and uses thereof | |
GB201421085D0 (en) | New enzyme inhibitors | |
EP3104915A4 (en) | Gas removal systems and methods | |
EP3362754A4 (en) | Proteasome inhibitors and uses thereof | |
EP3142659A4 (en) | Hiv-1 protease inhibitors and uses thereof | |
EP3177327A4 (en) | Inhibitors of myh7b and uses thereof | |
EP3247716A4 (en) | Mir-92 inhibitors and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20170608 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/00 20060101ALI20180719BHEP Ipc: A61P 27/06 20060101ALI20180719BHEP Ipc: A01N 57/00 20060101ALI20180719BHEP Ipc: A61K 38/00 20060101AFI20180719BHEP Ipc: A61K 38/05 20060101ALI20180719BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20181126 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/00 20060101ALI20181120BHEP Ipc: A61P 27/06 20060101ALI20181120BHEP Ipc: A01N 57/00 20060101AFI20181120BHEP Ipc: A61K 38/06 20060101ALI20181120BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20200708 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20201119 |